MC3 SORT LNP lipid mixtures

LNP formulationLiterature recipe

Stock-volume recipes for base MC3 LNP, 50% DOTAP lung SORT and 30% 18PA spleen SORT lipid mixtures.

Applicable scenario

Research formulations reported for MC3-based mRNA LNPs and the source's lung- or spleen-targeted SORT experiments. Select exactly one alternative. Organ-targeting labels describe the cited research models, not a prediction for another payload, species or clinical use.

Import to Workspace
QR code to import MC3 SORT LNP lipid mixtures into Listen Step Workspace

Open or scan to import into Workspace, jump to Modules and open this Recipe in the editor.

Import to the Android App instead · Download Recipe JSON

Formulation tables

Base MC3 LNP

ComponentStock concentrationVolume (µL)
DLin-MC3-DMA75 mg/mL13.3
DSPC10 mg/mL24.6
Cholesterol10 mg/mL46.4
DMG-PEG10 mg/mL11.7
Total lipid mixtureBase MC3 LNP96.0

50% DOTAP MC3 lung SORT LNP

ComponentStock concentrationVolume (µL)
DLin-MC3-DMA75 mg/mL13.3
DSPC10 mg/mL24.6
Cholesterol10 mg/mL46.4
DMG-PEG10 mg/mL11.7
DOTAP50 mg/mL43.5
Total lipid mixture50% DOTAP lung SORT139.5

30% 18PA MC3 spleen SORT LNP

ComponentStock concentrationVolume (µL)
DLin-MC3-DMA75 mg/mL13.3
DSPC10 mg/mL24.6
Cholesterol10 mg/mL46.4
DMG-PEG10 mg/mL11.7
18PA18.1 mg/mL in THF/ethanol (1:1)53.4
Total lipid mixture30% 18PA spleen SORT149.4

Source values and calculations

Literature source

Wang X et al. Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery. Nature Protocols 18, 265–291 (2023).

Source locator: Procedure, MC3 lipid stock and complete lipid-mix preparation, p. 8 in the extracted article PDF

Read the original source · DOI: 10.1038/s41596-022-00755-x

Editorial source check: 2026-11-09. Verify the original publication, actual stock concentrations and local safety requirements before use. Research use only; not clinical instructions.